medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2016, Número 4

<< Anterior

Rev Invest Clin 2016; 68 (4)


IKAROS Gene Deleted B-Cell Acute Lymphoblastic Leukemia in Mexican Mestizos: Observations in Seven Patients and a Short Review of the Literature

Ruiz-Delgado GJ, Cantero-Fortiz Y, León-Peña AA, León-González M, Nuñez-Cortés AK, Ruiz-Argüelles GJ

Idioma: Ingles.
Referencias bibliográficas: 33
Paginas: 210-214
Archivo PDF: 77.19 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Faderl S, Kantarjian HM, Talpaz M, Estrov Z. Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia. Blood. 1998;91:3995-4019.

  2. Pui CH, Robinson LL, Look AT. Acute lymphoblastic leukemia. Lancet. 2008;371:1030-43.

  3. Bleyer A, O’Leary M, Barr R, Ries LAG. Cancer epidemiology in older adolescents and young adults 15 to 29 years of age, including SEER incidence and survival: 1975-2000. National Cancer Institute, NIH Pub. No. 06-5767. Bethesda, MD. 2006.

  4. Ribera JM, Tormo M, Ortega JJ. [Acute lymphoblastic leukemia in adolescents and adults.] Med Clin Monogr (Barc). 2007; 129:36-9.

  5. Liu-Dumlao T, Kantarjian H, Thomas DA, O’Brien S, Ravandi F. Philadelphia-positive acute lymphoblastic leukemia: current treatment options. Curr Oncol Rep. 2012;14:387-94.

  6. Martinelli G, Iacobucci I, Storlazzi CT, et. al. IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: A GIMEMA AL WP report. J Clin Oncol. 2009;27:5202-7.

  7. Davis KL. Ikaros: master of hematopoiesis, agent of leukemia. Ther Adv Hematol. 2011;2:359-68.

  8. Bottardi S, Ross J, Bourgoin V, et al. Ikaros and GATA-1 combinatorial effect is required for silencing of human gamma-globin genes. Mol Cell Biol. 2009;29:1526-37.

  9. Winandy S, Wu P, Georgopoulos K. A dominant mutation in the ikaros gene leads to rapid development of leukemia and lymphoma. Cell. 1995;83:289-99.

  10. Payne KJ, Dovat S. Ikaros and tumor suppression in acute lymphoblastic leukemia. Crit Rev Oncog. 2011;16:3-12.

  11. Kathrein KL, Chari S, Winandy S. Ikaros directly represses the Notch target gene Hes 1 in a leukemia T cell line. Implications for CD4 regulation. J Biol Chem. 2008;283:10476-84.

  12. Ma S, Pathak S, Mandal M, Trinh L, Clark MR, Lu R. Ikaros and Aiolos inhibit Pre B-cell proliferation by directly suppressing c-Myc expression. Mol Cell Biol. 2010;30:4149-58.

  13. Gómez-del Arco P, Maki K , Georgopoulos K. Phosphorylation controls Ikaros ability to negatively regulate the G(1).S transition. Mol Cell Biol. 2004;24:2797-807.

  14. Kano G, Morimoto A, Takanashi M, Hibi S, Sugimoto T, Inaba T, et al. Ikaros dominant negative isoform (Ik6) induces IL-3 independent survival of murine pro B lymphocytes by activating JAK-STAT and up-regulating Bcl-xl levels. Leuk Lymphoma. 2008;49:965-73.

  15. Song C, Gowda C, Pan X, et al. Targeting casein kinase ll restores Ikaros tumor suppressor activity and demonstrates therapeutic efficacy in high-risk leukemia. Blood. 2015;126:1813-22.

  16. Stuppia L, Antonucci I, Palka G, Gatta V. Use of the MLPA assay in the molecular diagnosis of gene copy number alterations in human genetic diseases. Int J Mol Sci. 2012;13:3245-76.

  17. Ruiz-Delgado GJ, Macías-Gallardo J, Lutz-Presno J, Montes-Montiel M, Ruiz-Argüelles GJ. Outcome of adults with acute lymphoblastic leukemia treated with a pediatric-inspired therapy: A single institution experience. Leuk Lymphoma. 2011;52: 314-6.

  18. Molnár A, Wu P, Largespada DA, et al. The Ikaros gene encodes a family of lymphocyte-restricted zinc finger DNA binding proteins, highly conserved in human and mouse. J Immunol. 1996; 156:585-92.

  19. Koipally J, Heller EJ, Seavitt JR, Georgopoulos K. Unconventional potentiation of gene expression by Ikaros. J Biol Chem. 2002; 277:13007-15.

  20. Yoshida T, Georgopoulos K. Ikaros fingers on lymphocyte differentiation. Int J Hematol. 2014;100:220-9.

  21. Dijon M, Bardin F, Murati A, Batoz M, Chabannon C, Tonnelle C. The role of Ikaros in human erythroid differentiation. Blood. 2008;111:1138-46.

  22. O´Neill DW, Schoetz SS, Lopez RA, et al. An Ikaros -containing chromatin-remodeling complex in adult-type erythroid cells. Mol Cell Biol. 2000;20:7572-82.

  23. Molnár A, Geogopoulos K. The Ikaros gene encodes a family of functionally diverse zinc finger DNA- binding proteins. Mol Cell Biol. 1994;14:8292-303.

  24. Sun L, Liu A, Georgopolos K. Zinc finger-mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development. EMBO J. 1996;15:5358-69.

  25. Schwickert TA, Tagoh H, Gültekin S, et al. Stage-specific control of early B cell development by the transcription factor Ikaros. Nat Immunol. 2014;15:283-93.

  26. Bottardi S, Mavoungou L, Pak H, et al. The IKAROS Interaction with a complex including chromatin remodeling and transcription elongation activities is required for hematopoiesis. Plos Genet. 2014;10:e1004827.

  27. Tokunaga K, Yamaguchi S, Iwanaga E, et al. High frequency of IKZF1 genetic alterations in adult patients with B-cell acute lymphoblastic leukemia. Eur J Haematol. 2013;91: 201-8.

  28. Cytogenetic abnormalities in adult acute lymphoblastic leukemia: correlations with hematologic findings outcome. A collaborative study of The Group Français de Cytogénétique Hématologique. Blood. 1996;87:3135-42.

  29. Preti HA, O´Brien S, Giralt S, Beran M, Pierce S, Kantarjian HM. Philadelphia-chromosome-positive adult acute lymphocytic leukemia: characteristics, treatment results, and prognosis in 41 patients. Am J Med. 1994;97:60-5.

  30. Mulligham CG, Su X, Zhang J, et al. Children´s oncology group. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med. 2009;360:470-80.

  31. Eguigueren JM, Schell MJ, Crist WM, Kungel K, Rivera GK. Complications and outcome in childhood acute lymphoblastic leukemia. Blood. 1992;79:871-5.

  32. Pui CH, Pei D, Sandlund JT, et al. Long-term results of St. Jude total therapy studies 11, 12, 13A, 13B and 14 for childhood acute lymphoblastic leukemia. Leukemia. 2010;24:371-82.

  33. Barret AJ, Horowitz MM, Ash RC, et al. Bone marrow transplantation for Philadelphia chromosome- positive acute lymphoblastic leukemia. Blood. 1992;79:3067-7




2020     |     www.medigraphic.com